Search

everythinglearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Triamcinolone acetonide helps scalp grafts grow hair successfully.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

2.5 mg/ml of triamcinolone acetonide is more effective for treating alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.